SL
Shripal Lalchand Katariya
About Shripal Lalchand Katariya
Data last updated:
Shripal Lalchand Katariya is a Director at Narix Pharmaceuticals Private Limited (since 2022) and Designated Partner at O2 Global Ventures Llp (since 2021). The companies operate in Agriculture and Business Services. The largest current company by reported revenue is Narix Pharmaceuticals Private Limited at ₹1.26 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Narix Pharmaceuticals Private Limited U51220MH2022PTC393629 | Director | 16 Nov 2022 | 2022 | ₹1.26 Cr (FY 2025) | Active |
| O2 Global Ventures Llp AAV-9745 | Designated Partner | 19 Feb 2021 | 2021 | Active |
Board colleagues of Shripal Lalchand Katariya
| Name | DIN | Company | Designation |
|---|---|---|---|
| Naman Shripal Katariya | 09592070 | Narix Pharmaceuticals Private Limited , O2 Global Ventures Llp | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Shripal Lalchand Katariya
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Shripal Lalchand Katariya
Shripal Lalchand Katariya currently holds 2 directorships: Narix Pharmaceuticals Private Limited (Director, since 16 Nov 2022, revenue ₹1.26 Cr (FY 2025)); O2 Global Ventures Llp (Designated Partner, since 19 Feb 2021).
Shripal Lalchand Katariya was first appointed on 19 Feb 2021 as Designated Partner at O2 Global Ventures Llp. The most recent appointment on record is 16 Nov 2022 at Narix Pharmaceuticals Private Limited.
The current boards of Shripal Lalchand Katariya's companies include Naman Shripal Katariya (Narix Pharmaceuticals Private Limited).